Park Avenue Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $771K | Sell |
1,469
-11
| -0.7% | -$5.77K | 0.01% | 870 |
|
|
2025
Q1 | $938K | Sell |
1,480
-539
| -27% | -$342K | 0.01% | 645 |
|
|
2024
Q4 | $1.44M | Buy |
2,019
+130
| +7% | +$92.6K | 0.01% | 598 |
|
|
2024
Q3 | $1.99M | Buy |
1,889
+134
| +8% | +$141K | 0.02% | 436 |
|
|
2024
Q2 | $1.85M | Buy |
1,755
+84
| +5% | +$88.3K | 0.02% | 438 |
|
|
2024
Q1 | $1.61M | Buy |
1,671
+141
| +9% | +$136K | 0.02% | 481 |
|
|
2023
Q4 | $1.34M | Buy |
1,530
+101
| +7% | +$88.7K | 0.02% | 499 |
|
|
2023
Q3 | $1.18M | Buy |
+1,429
| New | +$1.18M | 0.02% | 496 |
|
|
2023
Q1 | – | Sell |
-1,111
| Closed | -$802K | – | 1063 |
|
|
2022
Q4 | $802K | Buy |
1,111
+64
| +6% | +$46.2K | 0.01% | 614 |
|
|
2022
Q3 | $721K | Buy |
1,047
+65
| +7% | +$44.8K | 0.01% | 591 |
|
|
2022
Q2 | $580K | Buy |
982
+122
| +14% | +$72.1K | 0.01% | 663 |
|
|
2022
Q1 | $601K | Sell |
860
-777
| -47% | -$543K | 0.01% | 669 |
|
|
2021
Q4 | $1.03M | Buy |
1,637
+948
| +138% | +$599K | 0.02% | 457 |
|
|
2021
Q3 | $417K | Sell |
689
-244
| -26% | -$148K | 0.01% | 717 |
|
|
2021
Q2 | $521K | Sell |
933
-173
| -16% | -$96.6K | 0.01% | 614 |
|
|
2021
Q1 | $523K | Buy |
1,106
+415
| +60% | +$196K | 0.01% | 570 |
|
|
2020
Q4 | $334K | Buy |
691
+305
| +79% | +$147K | 0.01% | 642 |
|
|
2020
Q3 | $216K | Buy |
+386
| New | +$216K | 0.01% | 689 |
|